Recently, the Centers for Medicare and Medicaid Services (CMS) recently announced that there will now be individual and unique Healthcare Common Procedure Coding System (HCPCS ) codes for biosimilars. Effective April 1, 2018, there is a new HCPCS code for INFLECTRA (infliximab-dyyb).
The HCPCS code is now Q5103 with no ZB modifier.
Providers may visit Pfizer enCompass™ website for more information on the updated HCPCS code for INFLECTRA as well as information on other reimbursement and support. You may also reach Pfizer enCompass™ at 1-844-722-6672 Monday–Friday, 9 AM–8 PM ET.